Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Milestone Pharmaceuticals Inc. (MIST)
USD1.29
+0.01 (+0.39%)
CA NASDAQ Healthcare Biotechnology
Address
1111 Dr. Frederik-Philips Boulevard H4M 2X6
Montreal, QC, CA
Montreal, QC, CA
CEO
Joseph G. Oliveto
Website
milestonepharma.com
IPO
2019-05-09
CIK 1408443 ISIN CA59935V1076
Description
Milestone Pharmaceuticals Inc. is a biopharmaceutical company based in Montréal, Canada, specializing in the creation and commercialization of cardiovascular therapeutics. Their flagship product, etripamil, an innovative channel blocker, is currently in advanced clinical development. It is undergoing Phase III trials for the treatment of paroxysmal supraventricular tachycardia (PSVT) in the United States and Canada, while also progressing through Phase II trials for atrial fibrillation and rapid ventricular rate. Furthermore, Milestone Pharmaceuticals has forged a licensing and collaboration alliance with Ji Xing Pharmaceuticals to advance and distribute etripamil for both preventative and therapeutic applications in humans. The company was founded in 2003.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.29
+0.01 (+0.39%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
0.97
Float Shares
84.72M
Free Float %
98.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | -5.00% | +11.76% | +0.00% | -5.94% | +59.66% | -54.87% | -63.88% | -87.64% | -87.64% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (7 ratings, all time)
Buy
Price Targets & DCF
Current price
1.29
Low
6.00
+366.9%
Consensus
7.33
+470.4%
Median
8.00
+522.6%
High
8.00
+522.6%
DCF (Unlevered)
0.15
-88.0%
DCF (Levered)
0.17
-87.0%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
83% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 4 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 1 |
6.00
+366.9%
|
| Last Year | 3 |
7.33
+470.4%
|
| All Time | 4 |
8.00
+522.6%
|
Quality scores
Altman Z-Score
-4.65
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%-11.9% Q1'26: +35.5% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-4,079.1% Q1'26: -6,745.0% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-4,041.7% Q1'26: +0.0% (vs Q1'25)
-
ROIC Biotechnology: -16.1%—
-
Share dilution Biotechnology: -3.4%+34.8% Q1'26: +96.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.94× Q1'26: -1.45× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 4 EPS Ana. |
Dec 2027 4 Rev. Ana. 4 EPS Ana. |
Dec 2028 2 Rev. Ana. 3 EPS Ana. |
Dec 2029 3 Rev. Ana. 2 EPS Ana. |
Dec 2030 3 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
15.00M
est: 15.00M (+0.0%)
|
5.00M
est: 2.00M (+150.0%)
|
1.00M
est: 1.00M (+0.0%)
|
—
est: 1.80M (-100.0%)
|
1.55M
est: 4.34M (-64.4%)
|
33.27M
4.32M – 87.94M
+666.8% YoY
|
28.87M
25.61M – 33.73M
-13.2% YoY
|
138.64M
62.42M – 272.85M
+380.1% YoY
|
230.15M
103.63M – 452.95M
+66.0% YoY
|
307.55M
138.48M – 605.28M
+33.6% YoY
|
| EBITDA |
-42.98M
est: -3.00M (-1,332.7%)
|
-58.30M
est: -400.0K (-14,474.8%)
|
-57.04M
est: -200.0K (-28,419.6%)
|
-37.83M
est: -1.08M (-3,403.1%)
|
-62.14M
est: -2.60M (-2,286.9%)
|
-19.96M
-52.77M – -2.59M
-666.8% YoY
|
-17.32M
-20.24M – -15.36M
+13.2% YoY
|
-83.18M
-163.71M – -37.45M
-380.1% YoY
|
-138.09M
-271.77M – -62.18M
-66.0% YoY
|
-184.53M
-363.17M – -83.09M
-33.6% YoY
|
| EBIT |
-43.07M
est: -3.00M (-1,335.8%)
|
-58.39M
est: -400.0K (-14,497.0%)
|
-57.13M
est: -200.0K (-28,465.6%)
|
-37.94M
est: -1.08M (-3,412.8%)
|
-62.49M
est: -2.60M (-2,300.1%)
|
-19.96M
-52.77M – -2.59M
-666.8% YoY
|
-17.32M
-20.24M – -15.36M
+13.2% YoY
|
-83.18M
-163.71M – -37.45M
-380.1% YoY
|
-138.09M
-271.77M – -62.18M
-66.0% YoY
|
-184.53M
-363.17M – -83.09M
-33.6% YoY
|
| Net Income |
-42.85M
est: -65.94M (+35.0%)
|
-58.39M
est: -88.65M (+34.1%)
|
-59.69M
est: -85.23M (+30.0%)
|
-41.52M
est: -52.68M (+21.2%)
|
-63.06M
est: -60.02M (-5.1%)
|
-36.49M
-57.45M – -4.66M
+39.2% YoY
|
-69.34M
-122.68M – -35.81M
-90.0% YoY
|
-18.66M
-42.15M – -5.33M
+73.1% YoY
|
17.83M
5.09M – 40.26M
+195.5% YoY
|
52.01M
14.84M – 117.46M
+191.8% YoY
|
| SGA |
19.40M
est: 117.91M (-83.5%)
|
24.81M
est: 15.72M (+57.8%)
|
31.05M
est: 7.86M (+295.0%)
|
27.75M
est: 17.81M (+55.8%)
|
17.27M
est: 42.93M (-59.8%)
|
329.25M
42.77M – 870.22M
+666.8% YoY
|
285.71M
253.40M – 333.75M
-13.2% YoY
|
1.37B
617.68M – 2.70B
+380.1% YoY
|
2.28B
1.03B – 4.48B
+66.0% YoY
|
3.04B
1.37B – 5.99B
+33.6% YoY
|
| EPS |
-1.02
est: -1.06 (+3.8%)
|
-1.35
est: -1.43 (+5.3%)
|
-1.39
est: -1.37 (-1.5%)
|
-0.67
est: -0.63 (-6.7%)
|
-0.75
est: -0.72 (-4.8%)
|
-0.44
-0.68 – -0.06
+39.2% YoY
|
-0.83
-1.46 – -0.43
-90.0% YoY
|
-0.22
-0.50 – -0.06
+73.1% YoY
|
0.21
0.06 – 0.48
+195.5% YoY
|
0.62
0.18 – 1.40
+191.8% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-11 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-08 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-07 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-06 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-05 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-04 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-01 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-15 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-49.11M
OE per share TTM
-0.70
Owner's Yield
-30.81%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
49.8%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
33
Total invested
3.74M
Insider transactions (90d)
1
Beneficial owners (>5%)
27
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GOLDMAN SACHS & CO. LLC | 2.75M | 8.00% | — | — | 13.00 | 2.75M | BD, IA, OO | Delaware | 2023-01-19 | ↗ |
| 2 | THE GOLDMAN SACHS GROUP, INC. | 2.75M | 8.00% | — | — | 13.00 | 2.75M | HC, CO | Delaware | 2023-01-19 | ↗ |
| 3 | OrbiMed Capital LLC | 2.58M | 8.70% | 2.58M | — | 2.58M | — | IA | Delaware | 2022-02-11 | ↗ |
| 4 | Peter Kolchinsky | 2.25M | 7.50% | — | 2.25M | — | 2.25M | HC, IN | Delaware | 2022-02-14 | ↗ |
| 5 | RA Capital Healthcare Fund, L.P. | 2.25M | 7.50% | — | 2.25M | — | 2.25M | PN | Delaware | 2022-02-14 | ↗ |
| 6 | RA Capital Management, L.P. | 2.25M | 7.50% | — | 2.25M | — | 2.25M | IA, PN | Delaware | 2022-02-14 | ↗ |
| 7 | Rajeev Shah | 2.25M | 7.50% | — | 2.25M | — | 2.25M | HC, IN | United States of America | 2022-02-14 | ↗ |
| 8 | Koh, Bong | 2.07M | 6.90% | — | 2.07M | — | — | IN | United States | 2022-09-20 | ↗ |
| 9 | Shah, Nimish | 2.07M | 6.90% | — | 2.07M | — | — | IN | United States | 2022-09-20 | ↗ |
| 10 | VHCP Co-Investment Holdings III, LLC | 2.07M | 6.90% | — | 2.07M | — | — | OO | Delaware | 2022-09-20 | ↗ |
| 11 | VHCP Management EG, LLC | 2.07M | 6.90% | — | 2.07M | — | — | OO | Delaware | 2022-09-20 | ↗ |
| 12 | VHCP Management III, LLC | 2.07M | 6.90% | — | 2.07M | — | — | OO | Delaware | 2022-09-20 | ↗ |
| 13 | Venrock Healthcare Capital Partners EG, L.P. | 2.07M | 6.90% | — | 2.07M | — | — | PN | Delaware | 2022-09-20 | ↗ |
| 14 | Venrock Healthcare Capital Partners III, L.P. | 2.07M | 6.90% | — | 2.07M | — | — | PN | Delaware | 2022-09-20 | ↗ |
| 15 | Israel A. Englander | 1.90M | 6.30% | — | 1.90M | — | 1.90M | IN | — | 2022-10-31 | ↗ |
| 16 | Millennium Group Management LLC | 1.90M | 6.30% | — | 1.90M | — | 1.90M | OO | — | 2022-10-31 | ↗ |
| 17 | Millennium Management LLC | 1.90M | 6.30% | — | 1.90M | — | 1.90M | OO | — | 2022-10-31 | ↗ |
| 18 | Chart Westcott | 1.75M | 5.90% | — | 1.75M | — | 1.75M | HC, IN | States | 2022-02-14 | ↗ |
| 19 | Ikarian Capital, LLC | 1.75M | 5.90% | — | 1.75M | — | 1.75M | IA | Delaware | 2022-02-14 | ↗ |
| 20 | Neil Shahrestani | 1.75M | 5.90% | — | 1.75M | — | 1.75M | HC, IN | States | 2022-02-14 | ↗ |
| 21 | Alta Fundamental Advisers LLC | 1.67M | 5.00% | — | — | — | 1.67M | IA, OO | — | 2023-11-09 | ↗ |
| 22 | Gilbert Li | 1.67M | 5.00% | — | — | — | 1.67M | HC, IN | — | 2023-11-09 | ↗ |
| 23 | Jeremy Carton | 1.67M | 5.00% | — | — | — | 1.67M | HC, IN | — | 2023-11-09 | ↗ |
| 24 | Integrated Core Strategies (US) LLC | 1.60M | 5.30% | — | 1.60M | — | 1.60M | OO | — | 2022-10-31 | ↗ |
| 25 | des travailleurs du Québec (F.T.Q.) | 1.39M | 4.70% | 1.39M | — | 1.39M | — | IV | — | 2021-02-12 | ↗ |
| 26 | Novo Holdings A/S | 1.38M | 4.60% | 1.38M | — | 1.38M | — | CO | — | 2022-10-24 | ↗ |
| 27 | 52-0556948 | 375.0K | 1.20% | 55.5K | — | 375.0K | — | IA | Maryland | 2021-02-16 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
33
-53 vs prev Q
New positions
10
Closed positions
56
Increased
18
Reduced
5
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | PROPEL BIO MANAGEMENT, LLC | 4.12M -1.0M (-19.6%) | 8.32M -1.9M (-18.8%) | 6.20% -1.516 pp | 7.10% -3.158 pp | USD1.66 +21.7% | 4 qtrs — |
| 2 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.81M -4.2M (-59.7%) | 5.68M -8.3M (-59.3%) | 4.23% -6.276 pp | 0.01% -0.014 pp | USD2.00 +1.0% | 2 qtrs — |
| 3 | RTW INVESTMENTS, LP | 2.51M +— (+0.0%) | 5.06M +50.1K (+1.0%) | 3.78% +0.000 pp | 0.05% -0.011 pp | USD22.96 -91.2% | 27 qtrs — |
| 4 | MARSHALL WACE, LLP | 1.66M +1.2M (+289.8%) | 3.35M +2.5M (+293.7%) | 2.50% +1.856 pp | 0.00% +0.002 pp | USD2.01 +0.5% | 2 qtrs — |
| 5 | TWO SIGMA INVESTMENTS, LP | 1.51M +847.9K (+127.2%) | 3.06M +1.7M (+129.5%) | 2.28% +1.277 pp | 0.00% +0.002 pp | USD2.01 +0.5% | 2 qtrs — |
| 6 | SIMPLIFY ASSET MANAGEMENT INC. | 1.51M -1.3M (-46.8%) | 3.04M -2.6M (-46.3%) | 2.27% -1.998 pp | 0.05% -0.055 pp | USD1.64 +23.2% | 4 qtrs — |
| 7 | PATHSTONE HOLDINGS, LLC | 1.02M +17.0K (+1.7%) | 2.10M +104.4K (+5.2%) | 1.53% +0.026 pp | 0.01% +0.001 pp | USD2.00 +1.0% | 2 qtrs — |
| 8 | MORGAN STANLEY | 781.9K -2.2M (-73.7%) | 1.58M -4.4M (-73.4%) | 1.18% -3.295 pp | 0.00% 0.000 pp | USD2.55 -20.8% | 27 qtrs — |
| 9 | LION POINT CAPITAL, LP | 755.0K +96.4K (+14.6%) | 1.53M +208.0K (+15.8%) | 1.14% +0.145 pp | 7.89% +0.410 pp | USD2.56 -21.1% | 16 qtrs — |
| 10 | TORONTO DOMINION BANK | 750.0K +— (+0.0%) | 1.52M +15.0K (+1.0%) | 1.13% +0.000 pp | 0.00% 0.000 pp | USD2.36 -14.4% | 5 qtrs — |
| 11 | BOXER CAPITAL MANAGEMENT, LLC | 666.7K +— (+0.0%) | 1.35M +13.3K (+1.0%) | 1.00% +0.000 pp | 0.29% -0.130 pp | USD2.00 +1.0% | 2 qtrs — |
| 12 | STONEPINE CAPITAL MANAGEMENT, LLC | 662.7K +662.7K (+100.0%) | 1.34M +1.3M (+100.0%) | 1.00% +0.998 pp | 0.98% +0.977 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 13 | TWO SIGMA ADVISERS, LP | 619.6K +385.6K (+164.7%) | 1.25M +783.5K (+167.4%) | 0.93% +0.581 pp | 0.00% +0.002 pp | USD2.01 +0.5% | 4 qtrs — |
| 14 | UBS GROUP AG | 491.9K +94.3K (+23.7%) | 993.6K +198.5K (+25.0%) | 0.74% +0.142 pp | 0.00% +0.000 pp | USD1.99 +1.5% | 5 qtrs — |
| 15 | POINT72 ASSET MANAGEMENT, L.P. | 482.4K +482.4K (+100.0%) | 974.4K +974.4K (+100.0%) | 0.73% +0.727 pp | 0.00% +0.001 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 16 | MILLENNIUM MANAGEMENT LLC | 402.6K +1.1K (+0.3%) | 813.3K +10.2K (+1.3%) | 0.61% +0.002 pp | 0.00% +0.000 pp | USD2.00 +1.0% | 27 qtrs — |
| 17 | APTUS CAPITAL ADVISORS, LLC | 263.2K +53.0K (+25.2%) | 531.7K +111.3K (+26.5%) | 0.40% +0.080 pp | 0.00% +0.001 pp | USD2.00 +1.0% | 2 qtrs — |
| 18 | GUARDIAN WEALTH ADVISORS, LLC / NC | 263.2K +53.0K (+25.2%) | 531.7K +111.3K (+26.5%) | 0.40% +0.080 pp | 0.03% +0.006 pp | USD2.00 +1.0% | 2 qtrs — |
| 19 | SQUAREPOINT OPS LLC | 249.3K +249.3K (+100.0%) | 503.7K +503.7K (+100.0%) | 0.38% +0.376 pp | 0.00% +0.001 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 20 | CITADEL ADVISORS LLC | 237.8K +175.2K (+279.9%) | 480.4K +355.2K (+283.7%) | 0.36% +0.264 pp | 0.00% +0.000 pp | USD2.00 +1.0% | 5 qtrs — |
| 21 | GSA CAPITAL PARTNERS LLP | 236.1K +157.4K (+199.9%) | 477.0K +320.0K (+203.8%) | 0.36% +0.237 pp | 0.04% +0.028 pp | USD2.01 +0.5% | 2 qtrs — |
| 22 | NOMURA HOLDINGS INC | 225.0K +225.0K (+100.0%) | 454.5K +454.5K (+100.0%) | 0.34% +0.339 pp | 0.00% +0.001 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 23 | BNP PARIBAS ARBITRAGE, SNC | 222.0K +222.0K (+100.0%) | 448.3K +448.3K (+100.0%) | 0.33% +0.334 pp | 0.00% +0.000 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 24 | GROUP ONE TRADING, L.P. | 195.1K +188.1K (+2,678.4%) | 394.1K +380.1K (+2,706.2%) | 0.29% +0.283 pp | 0.00% +0.001 pp | USD2.00 +1.0% | 5 qtrs — |
| 25 | ACADIAN ASSET MANAGEMENT LLC | 176.2K +176.2K (+100.0%) | 353.0K +353.0K (+100.0%) | 0.27% +0.265 pp | 0.00% +0.001 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 26 | XTX TOPCO LTD | 172.0K -15.3K (-8.2%) | 347.4K -27.2K (-7.3%) | 0.26% -0.023 pp | 0.01% -0.010 pp | USD1.92 +5.2% | 5 qtrs — |
| 27 | LPL FINANCIAL LLC | 142.5K +47.2K (+49.5%) | 287.8K +97.2K (+51.0%) | 0.21% +0.071 pp | 0.00% +0.000 pp | USD1.91 +5.8% | 4 qtrs — |
| 28 | GRAHAM CAPITAL MANAGEMENT, L.P. | 133.6K +133.6K (+100.0%) | 269.9K +269.9K (+100.0%) | 0.20% +0.201 pp | 0.01% +0.007 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 29 | VALEO FINANCIAL ADVISORS, LLC | 130.7K +— (+0.0%) | 264.0K +2.6K (+1.0%) | 0.20% +0.000 pp | 0.01% 0.000 pp | USD2.31 -12.6% | 14 qtrs — |
| 30 | ADAR1 CAPITAL MANAGEMENT, LLC | 100.1K +100.1K (+100.0%) | 202.2K +202.2K (+100.0%) | 0.15% +0.151 pp | 0.01% +0.015 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 31 | TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | 100.0K +100.0K (+100.0%) | 202.0K +202.0K (+100.0%) | 0.15% +0.151 pp | 0.13% +0.126 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 32 | SG AMERICAS SECURITIES, LLC | 97.4K +97.4K (+100.0%) | 197.0K +197.0K (+100.0%) | 0.15% +0.147 pp | 0.00% +0.000 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 33 | JANE STREET GROUP, LLC | 78.9K +78.9K (+100.0%) | 159.4K +159.4K (+100.0%) | 0.12% +0.119 pp | 0.00% +0.000 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 34 | CASCADES CAPITAL ASSET MANAGEMENT, LLC | 77.5K +175.0 (+0.2%) | 156.6K +1.9K (+1.2%) | 0.12% +0.000 pp | 0.07% -0.003 pp | USD1.95 +3.6% | 3 qtrs — |
| 35 | GEODE CAPITAL MANAGEMENT, LLC | 74.0K +— (+0.0%) | 149.5K +1.5K (+1.0%) | 0.11% +0.000 pp | 0.00% +0.000 pp | USD2.62 -22.9% | 23 qtrs — |
| 36 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 73.2K -8.0K (-9.9%) | 147.9K -14.5K (-9.0%) | 0.11% -0.012 pp | 0.00% +0.000 pp | USD1.57 +28.7% | 7 qtrs — |
| 37 | ENGINEERS GATE MANAGER LP | 59.1K +59.1K (+100.0%) | 119.3K +119.3K (+100.0%) | 0.09% +0.089 pp | 0.00% +0.001 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 38 | OCTOBER EFFECT LTD | 52.1K +52.1K (+100.0%) | 105.2K +105.2K (+100.0%) | 0.08% +0.079 pp | 0.12% +0.116 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 39 | CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 47.1K +34.4K (+271.2%) | 95.0K +70.0K (+280.0%) | 0.07% +0.052 pp | 0.00% +0.000 pp | USD2.01 +0.5% | 2 qtrs — |
| 40 | NORTHERN TRUST CORP | 39.3K +— (+0.0%) | 79.3K +785.0 (+1.0%) | 0.06% +0.000 pp | 0.00% +0.000 pp | USD2.04 -1.0% | 9 qtrs — |
| 41 | COLONY GROUP, LLC | 36.0K +— (+0.0%) | 72.7K +720.0 (+1.0%) | 0.05% +0.000 pp | 0.00% +0.000 pp | USD1.94 +4.1% | 3 qtrs — |
| 42 | QUBE RESEARCH & TECHNOLOGIES LTD | 34.6K +34.6K (+100.0%) | 69.9K +69.9K (+100.0%) | 0.05% +0.052 pp | 0.00% +0.000 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 43 | CITIGROUP INC | 33.9K +26.0K (+333.4%) | 68.4K +52.8K (+337.7%) | 0.05% +0.039 pp | 0.00% +0.000 pp | USD2.02 +0.0% | 5 qtrs — |
| 44 | SCIENTECH RESEARCH LLC | 30.1K +30.1K (+100.0%) | 60.9K +60.9K (+100.0%) | 0.05% +0.045 pp | 0.04% +0.038 pp | USD2.02 +0.0% | 4 qtrs — |
| 45 | FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 29.8K +— (+0.0%) | 60.2K +596.0 (+1.0%) | 0.04% +0.000 pp | 0.00% +0.000 pp | USD6.99 -71.1% | 27 qtrs — |
| 46 | BAY RIVERS GROUP | 28.9K +12.2K (+72.9%) | 58.3K +24.9K (+74.6%) | 0.04% +0.018 pp | 0.02% +0.010 pp | USD1.98 +2.0% | 3 qtrs — |
| 47 | RAYMOND JAMES FINANCIAL INC | 26.6K +— (+0.0%) | 53.7K +532.0 (+1.0%) | 0.04% +0.000 pp | 0.00% +0.000 pp | USD1.06 +90.6% | 4 qtrs — |
| 48 | SAFEGUARD INVESTMENT ADVISORY GROUP, LLC | 25.0K +— (+0.0%) | 50.6K +501.0 (+1.0%) | 0.04% +0.000 pp | 0.01% +0.001 pp | USD0.80 +152.5% | 4 qtrs — |
| 49 | MARINER, LLC | 25.0K +— (+0.0%) | 50.5K +500.0 (+1.0%) | 0.04% +0.000 pp | 0.00% +0.000 pp | USD1.97 +2.5% | 3 qtrs — |
| 50 | CREATIVE PLANNING | 23.4K +— (+0.0%) | 47.3K +468.0 (+1.0%) | 0.04% +0.000 pp | 0.00% +0.000 pp | USD3.03 -33.3% | 13 qtrs — |
| 51 | INVESCO LTD. | 21.9K +21.9K (+100.0%) | 44.2K +44.2K (+100.0%) | 0.03% +0.033 pp | 0.00% +0.000 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 52 | STATE STREET CORP | 21.9K -345.0 (-1.6%) | 44.2K -252.0 (-0.6%) | 0.03% -0.001 pp | 0.00% +0.000 pp | USD6.02 -66.4% | 22 qtrs — |
| 53 | CETERA INVESTMENT ADVISERS | 20.7K +20.7K (+100.0%) | 41.9K +41.9K (+100.0%) | 0.03% +0.031 pp | 0.00% +0.000 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 54 | STEPHENSON & COMPANY, INC. | 20.0K +— (+0.0%) | 40.4K +400.0 (+1.0%) | 0.03% +0.000 pp | 0.02% -0.001 pp | USD2.00 +1.0% | 2 qtrs — |
| 55 | QUANTBOT TECHNOLOGIES LP | 19.0K +19.0K (+100.0%) | 38.4K +38.4K (+100.0%) | 0.03% +0.029 pp | 0.00% +0.001 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 56 | NATIONAL BANK OF CANADA /FI/ | 18.7K +— (+0.0%) | 37.8K +374.0 (+1.0%) | 0.03% +0.000 pp | 0.00% +0.000 pp | USD2.39 -15.5% | 17 qtrs — |
| 57 | BAYESIAN CAPITAL MANAGEMENT, LP | 17.2K +17.2K (+100.0%) | 34.8K +34.8K (+100.0%) | 0.03% +0.026 pp | 0.08% +0.080 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 58 | JONES FINANCIAL COMPANIES LLLP | 16.0K +5.0K (+45.5%) | 32.3K +10.3K (+46.9%) | 0.02% +0.008 pp | 0.00% +0.000 pp | USD2.19 -7.8% | 7 qtrs — |
| 59 | SJS INVESTMENT CONSULTING INC. | 15.0K +15.0K (+100.0%) | 30.3K +30.3K (+100.0%) | 0.02% +0.023 pp | 0.00% +0.004 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 60 | BETA WEALTH GROUP, INC. | 14.1K +— (+0.0%) | 28.5K +283.0 (+1.0%) | 0.02% +0.000 pp | 0.01% +0.000 pp | USD2.85 -29.1% | 13 qtrs — |
| 61 | EATON FINANCIAL HOLDINGS COMPANY, LLC | 12.8K +12.8K (+100.0%) | 25.8K +25.8K (+100.0%) | 0.02% +0.019 pp | 0.01% +0.007 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 62 | STRATEGIC FAMILY WEALTH COUNSELORS, L.L.C. | 12.7K +12.7K (+100.0%) | 25.5K +25.5K (+100.0%) | 0.02% +0.019 pp | 0.01% +0.006 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 63 | BRONTE CAPITAL MANAGEMENT PTY LTD. | 10.4K +10.4K (+100.0%) | 21.0K +21.0K (+100.0%) | 0.02% +0.016 pp | 0.00% +0.002 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 64 | TAYLOR FINANCIAL GROUP, INC. | 10.0K +— (+0.0%) | 20.2K +200.0 (+1.0%) | 0.02% +0.000 pp | 0.01% +0.000 pp | USD1.94 +4.1% | 3 qtrs — |
| 65 | ANCORA ADVISORS, LLC | 10.0K +— (+0.0%) | 20.2K +200.0 (+1.0%) | 0.02% +0.000 pp | 0.00% +0.000 pp | USD1.70 +18.8% | 9 qtrs — |
| 66 | SECURE ASSET MANAGEMENT, LLC | 10.0K +— (+0.0%) | 20.2K -300.0 (-1.5%) | 0.02% +0.000 pp | 0.00% 0.000 pp | USD2.00 +1.0% | 2 qtrs — |
| 67 | AQR CAPITAL MANAGEMENT LLC | 10.0K +— (+0.0%) | 20.2K +200.0 (+1.0%) | 0.02% +0.000 pp | 0.00% +0.000 pp | USD2.00 +1.0% | 2 qtrs — |
| 68 | INTEGRAL INVESTMENT ADVISORS, INC. | 10.0K +10.0K (+100.0%) | 20.2K +20.2K (+100.0%) | 0.02% +0.015 pp | 0.01% +0.005 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 69 | TOWER RESEARCH CAPITAL LLC (TRC) | 9.0K +9.0K (+100.0%) | 18.1K +18.1K (+100.0%) | 0.01% +0.014 pp | 0.00% +0.000 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 70 | ROYAL BANK OF CANADA | 6.7K -136.7K (-95.3%) | 13.0K -274.0K (-95.5%) | 0.01% -0.206 pp | 0.00% +0.000 pp | USD1.91 +5.8% | 6 qtrs — |
| 71 | US BANCORP \DE\ | 3.2K +— (+0.0%) | 6.5K +64.0 (+1.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.80 +152.5% | 4 qtrs — |
| 72 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | 1.7K +1.7K (+100.0%) | 3.4K +3.4K (+100.0%) | 0.00% +0.003 pp | 0.00% +0.000 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 73 | SRS CAPITAL ADVISORS, INC. | 1.6K +514.0 (+47.7%) | 3.2K +1.1K (+49.2%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD2.01 +0.5% | 2 qtrs — |
| 74 | BANK OF AMERICA CORP /DE/ | 841.00 -15.2K (-94.8%) | 1.7K -30.4K (-94.7%) | 0.00% -0.023 pp | 0.00% +0.000 pp | USD2.00 +1.0% | 4 qtrs — |
| 75 | RIALTO WEALTH MANAGEMENT, LLC | 300.00 +300.0 (+100.0%) | 606.00 +606.0 (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 76 | JOURNEY STRATEGIC WEALTH LLC | 10.0K +10.0K (+100.0%) | 500.00 +500.0 (+100.0%) | 0.02% +0.015 pp | 0.00% +0.000 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 77 | — | 212.00 +212.0 (+100.0%) | 428.00 +428.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.02 +0.0% | 1 qtrs NEW |
| 78 | SBI SECURITIES CO., LTD. | 6.00 +— (+0.0%) | 12.00 +— (+0.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.00 +102.0% | 4 qtrs — |
| 79 | HRT FINANCIAL LP | — -138.8K (-100.0%) | — -277.0K (-100.0%) | 0.00% -0.209 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
| 80 | ORBIMED ADVISORS LLC | — -3.2M (-100.0%) | — -6.4M (-100.0%) | 0.00% -4.854 pp | 0.00% -0.152 pp | USD— | 2 qtrs SOLD |
| 81 | BARCLAYS PLC | — -100.0 (-100.0%) | — -152.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 82 | SPHERA FUNDS MANAGEMENT LTD. | — -820.0K (-100.0%) | — -1.6M (-100.0%) | 0.00% -1.235 pp | 0.00% -0.346 pp | USD— | 2 qtrs SOLD |
| 83 | QUADRATURE CAPITAL LTD | — -223.5K (-100.0%) | — -448.1K (-100.0%) | 0.00% -0.337 pp | 0.00% -0.005 pp | USD— | 2 qtrs SOLD |
| 84 | SIMPLEX TRADING, LLC | — -66.9K (-100.0%) | — -133.0K (-100.0%) | 0.00% -0.101 pp | 0.00% 0.000 pp | USD— | 11 qtrs SOLD |
| 85 | WEALTHSPIRE ADVISORS, LLC | — -1.1K (-100.0%) | — -2.3K (-100.0%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 86 | AFFINITY ASSET ADVISORS, LLC | — -666.7K (-100.0%) | — -1.3M (-100.0%) | 0.00% -1.004 pp | 0.00% -0.116 pp | USD— | 2 qtrs SOLD |
| 87 | GOLDMAN SACHS GROUP INC | — -356.6K (-100.0%) | — -713.1K (-100.0%) | 0.00% -0.537 pp | 0.00% 0.000 pp | USD— | 22 qtrs SOLD |
| 88 | SAPIENT CAPITAL LLC | — -12.2K (-100.0%) | — -24.8K (-100.0%) | 0.00% -0.018 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.25
Neutral
Ratio by volume
3.00
Bullish
Buys
15
Sells
12
Shares acquired
2.64M
Shares disposed
272.9K
Cash buys
—
Cash sales
7.00
Net activity
+2,366,062
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-16 | Oliveto Joseph | Director / Officer | S-Sale | D | Common Shares | 36,500 | 2.26 | 82.5K | 446,244 | D | ↗ |
| 2026-03-17 | Sandoval David I. | Officer | — | — | Employee Stock Option (right to buy) | 400,000 | 1.96 | 784.0K | 0 | D | ↗ |
| 2026-02-02 | Oliveto Joseph | Director / Officer | A-Award | A | Restricted Stock Unit | 453,000 | 0.00 | — | 453,000 | D | ↗ |
| 2026-02-02 | Nelson Jeffrey Edward | Officer | A-Award | A | Employee Stock Option (right to buy) | 204,000 | 1.97 | 401.9K | 204,000 | D | ↗ |
| 2026-02-02 | Muller Lorenz | Officer | A-Award | A | Restricted Stock Unit | 136,000 | 0.00 | — | 136,000 | D | ↗ |
| 2026-02-02 | Hasija Amit | Officer | A-Award | A | Employee Stock Option (right to buy) | 204,000 | 1.97 | 401.9K | 204,000 | D | ↗ |
| 2026-02-02 | Bharucha David | Officer | A-Award | A | Restricted Stock Unit | 136,000 | 0.00 | — | 136,000 | D | ↗ |
| 2026-01-26 | Oliveto Joseph | Director / Officer | M-Exempt | A | Common Shares | 66,600 | 0.00 | — | 517,267 | D | ↗ |
| 2026-01-26 | Nelson Jeffrey Edward | Officer | M-Exempt | D | Restricted Stock Units | 20,100 | 0.00 | — | 60,300 | D | ↗ |
| 2026-01-26 | Muller Lorenz | Officer | M-Exempt | D | Restricted Stock Units | 20,100 | 0.00 | — | 60,300 | D | ↗ |
| 2026-01-26 | Hasija Amit | Officer | S-Sale | D | Common Shares | 12,245 | 1.93 | 23.6K | 99,848 | D | ↗ |
| 2026-01-26 | Bharucha David | Officer | S-Sale | D | Common Shares | 12,245 | 1.93 | 23.6K | 113,181 | D | ↗ |
| 2026-01-08 | Oliveto Joseph | Director / Officer | S-Sale | D | Common Shares | 43,000 | 2.25 | 96.8K | 303,721 | D | ↗ |
| 2026-01-07 | Oliveto Joseph | Director / Officer | S-Sale | D | Common Shares | 500 | 2.25 | 1.1K | 346,721 | D | ↗ |
| 2025-12-15 | Oliveto Joseph | Director / Officer | S-Sale | D | Common Shares | 133,054 | 2.32 | 308.7K | 450,667 | D | ↗ |
| 2025-12-15 | Nelson Jeffrey Edward | Officer | S-Sale | D | Common Shares | 58,007 | 2.32 | 134.6K | 41,993 | D | ↗ |
| 2025-12-15 | Muller Lorenz | Officer | S-Sale | D | Common Shares | 53,566 | 2.32 | 124.3K | 196,486 | D | ↗ |
| 2025-12-15 | Hasija Amit | Officer | S-Sale | D | Common Shares | 58,007 | 2.32 | 134.6K | 91,993 | D | ↗ |
| 2025-12-15 | Bharucha David | Officer | S-Sale | D | Common Shares | 58,007 | 2.32 | 134.6K | 105,326 | D | ↗ |
| 2025-12-12 | Oliveto Joseph | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 280,000 | 1.74 | 487.2K | 280,000 | D | ↗ |
| 2025-12-12 | Nelson Jeffrey Edward | Officer | A-Award | A | Common Shares | 100,000 | 0.00 | — | 100,000 | D | ↗ |
| 2025-12-12 | Muller Lorenz | Officer | A-Award | A | Common Shares | 100,000 | 0.00 | — | 250,052 | D | ↗ |
| 2025-12-12 | Hasija Amit | Officer | A-Award | A | Employee Stock Option (right to buy) | 100,000 | 1.74 | 174.0K | 100,000 | D | ↗ |
| 2025-12-12 | Bharucha David | Officer | A-Award | A | Employee Stock Option (right to buy) | 100,000 | 1.74 | 174.0K | 100,000 | D | ↗ |
| 2025-12-09 | Muller Lorenz | Officer | G-Gift | D | Common Shares | 25,000 | 0.00 | — | 150,052 | D | ↗ |
| 2025-07-11 | Wills Robert James | Director | A-Award | A | Series B Common Warrants (right to buy) | 50,000 | 1.88 | 93.8K | 50,000 | D | ↗ |
| 2025-07-11 | PAPA JOSEPH C | Director | A-Award | A | Series A Common Warrants (right to buy) | 100,000 | 1.50 | 150.0K | 100,000 | D | ↗ |
| 2025-07-11 | Oliveto Joseph | Director / Officer | A-Award | A | Common Shares | 66,666 | 1.50 | 100.0K | 347,221 | D | ↗ |
| 2025-07-11 | Muller Lorenz | Officer | A-Award | A | Common Shares | 66,666 | 1.50 | 100.0K | 175,052 | D | ↗ |
| 2025-07-11 | Liebert Debra K. | Director | A-Award | A | Common Shares | 16,666 | 1.50 | 25.0K | 16,793 | D | ↗ |
| 2025-07-11 | Hasija Amit | Officer | A-Award | A | Series A Common Warrants (right to buy) | 50,000 | 1.50 | 75.0K | 50,000 | D | ↗ |
| 2025-07-11 | Bharucha David | Officer | A-Award | A | Series A Common Warrants (right to buy) | 53,333 | 1.50 | 80.0K | 53,333 | D | ↗ |
| 2025-06-10 | Wills Robert James | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 1.75 | 70.0K | 40,000 | D | ↗ |
| 2025-06-10 | TOMSICEK MICHAEL JOHN | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 1.75 | 70.0K | 40,000 | D | ↗ |
| 2025-06-10 | Saik Andrew | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 1.75 | 70.0K | 40,000 | D | ↗ |
| 2025-06-10 | PAPA JOSEPH C | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 1.75 | 70.0K | 40,000 | D | ↗ |
| 2025-06-10 | Giles Lisa M. | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 1.75 | 70.0K | 40,000 | D | ↗ |
| 2025-06-10 | Fischer Seth H. Z. | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 1.75 | 70.0K | 40,000 | D | ↗ |
| 2025-06-10 | Duty Stuart | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 1.75 | 70.0K | 40,000 | D | ↗ |
| 2025-01-27 | Oliveto Joseph | Director / Officer | A-Award | A | Restricted Stock Unit | 266,400 | 0.00 | — | 266,400 | D | ↗ |
| 2025-01-27 | Nelson Jeffrey Edward | Officer | A-Award | A | Restricted Stock Unit | 80,400 | 0.00 | — | 80,400 | D | ↗ |
| 2025-01-27 | Muller Lorenz | Officer | A-Award | A | Restricted Stock Unit | 80,400 | 0.00 | — | 80,400 | D | ↗ |
| 2025-01-27 | Hasija Amit | Officer | A-Award | A | Employee Stock Option (right to buy) | 120,600 | 2.02 | 243.6K | 120,600 | D | ↗ |
| 2025-01-27 | Bharucha David | Officer | A-Award | A | Restricted Stock Unit | 80,400 | 0.00 | — | 80,400 | D | ↗ |
| 2024-09-03 | PAPA JOSEPH C | Director | A-Award | A | Stock Option (right to buy) | 80,000 | 1.39 | 111.2K | 80,000 | — | ↗ |
| 2024-08-28 | Wills Robert James | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 1.45 | 58.0K | 40,000 | — | ↗ |
| 2024-08-28 | TOMSICEK MICHAEL JOHN | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 1.45 | 58.0K | 40,000 | — | ↗ |
| 2024-08-28 | Saik Andrew | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 1.45 | 58.0K | 40,000 | — | ↗ |
| 2024-08-28 | Giles Lisa M. | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 1.45 | 58.0K | 40,000 | — | ↗ |
| 2024-08-28 | Fischer Seth H. Z. | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 1.45 | 58.0K | 40,000 | — | ↗ |
| 2024-08-28 | Duty Stuart | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 1.45 | 58.0K | 40,000 | — | ↗ |
| 2024-07-15 | Saik Andrew | Director | A-Award | D | Stock Option (right to buy) | 80,000 | 1.59 | 126.8K | 80,000 | — | ↗ |
| 2024-07-15 | Duty Stuart | Director | A-Award | D | Stock Option (right to buy) | 80,000 | 1.59 | 126.8K | 80,000 | — | ↗ |
| 2023-06-07 | Wills Robert James | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 3.86 | 115.8K | 30,000 | — | ↗ |
| 2023-06-07 | TOMSICEK MICHAEL JOHN | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 3.86 | 115.8K | 30,000 | — | ↗ |
| 2023-06-07 | Pasternak Richard C | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 3.86 | 115.8K | 30,000 | — | ↗ |
| 2023-06-07 | Liebert Debra K. | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 3.86 | 115.8K | 30,000 | — | ↗ |
| 2023-06-07 | Giles Lisa M. | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 3.86 | 115.8K | 30,000 | — | ↗ |
| 2023-06-07 | Fischer Seth H. Z. | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 3.86 | 115.8K | 30,000 | — | ↗ |
| 2023-03-22 | RTW INVESTMENTS, LP | 10% Owner | J-Other | D | Common Shares, no par value ("Common Shares") | 1,059,000 | 0.00 | 1.1K | 3,256,102 | — | ↗ |
| 2023-03-21 | Fischer Seth H. Z. | Director | A-Award | A | Stock Option (right to buy) | 42,000 | 3.45 | 144.9K | 42,000 | — | ↗ |
| 2023-02-16 | Oliveto Joseph | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 360,000 | 3.59 | 1.29M | 360,000 | — | ↗ |
| 2023-02-16 | Nelson Jeffrey Edward | Officer | A-Award | A | Employee Stock Option (right to buy) | 105,000 | 3.59 | 377.0K | 105,000 | — | ↗ |
| 2023-02-16 | Muller Lorenz | Officer | A-Award | A | Employee Stock Option (right to buy) | 105,000 | 3.59 | 377.0K | 105,000 | — | ↗ |
| 2023-02-16 | Hasija Amit | Officer | A-Award | A | Employee Stock Option (right to buy) | 130,000 | 3.59 | 466.7K | 130,000 | — | ↗ |
| 2023-02-16 | Bharucha David | Officer | A-Award | A | Employee Stock Option (right to buy) | 185,000 | 3.59 | 664.2K | 185,000 | — | ↗ |
| 2022-12-05 | Bharucha David | Officer | P-Purchase | A | Common Shares | 7,000 | 4.69 | 32.8K | 10,000 | — | ↗ |
| 2022-12-01 | Bharucha David | Officer | P-Purchase | A | Common Shares | 3,000 | 4.86 | 14.6K | 3,000 | — | ↗ |
| 2022-10-21 | Liebert Debra K. | Director | P-Purchase | A | Common Shares | 4,000 | 5.26 | 21.0K | 4,000 | — | ↗ |
| 2022-10-20 | Pasternak Richard C | Director | P-Purchase | A | Common Shares | 10,000 | 5.20 | 52.0K | 10,000 | — | ↗ |
| 2022-10-20 | Liebert Debra K. | Director | P-Purchase | A | Common Shares | 10,000 | 5.29 | 52.9K | 10,000 | — | ↗ |
| 2022-10-19 | Wills Robert James | Director | P-Purchase | A | Common Shares | 15,000 | 4.93 | 74.0K | 15,000 | — | ↗ |
| 2022-10-19 | TOMSICEK MICHAEL JOHN | Director | P-Purchase | A | Common Shares | 15,000 | 5.32 | 79.8K | 15,000 | — | ↗ |
| 2022-09-14 | Liebert Debra K. | Director | J-Other | A | Common Shares | 127 | 0.00 | — | 127 | — | ↗ |
| 2022-09-07 | WONG RODERICK | Director | P-Purchase | A | Common Shares, no par value ("Common Shares") | 1,557,346 | 8.71 | 13.56M | 4,315,102 | — | ↗ |
| 2022-09-07 | RTW INVESTMENTS, LP | 10% Owner | S-Sale | D | Common Shares | 1,557,346 | 8.71 | 13.56M | 4,315,102 | — | ↗ |
| 2022-08-09 | Nelson Jeffrey Edward | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-07-05 | Wills Robert James | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 6.07 | 182.1K | 30,000 | — | ↗ |
| 2022-07-05 | TOMSICEK MICHAEL JOHN | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 0.00 | — | 30,000 | — | ↗ |
| 2022-07-05 | Pasternak Richard C | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 0.00 | — | 30,000 | — | ↗ |
| 2022-07-05 | Liebert Debra K. | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 6.07 | 182.1K | 30,000 | — | ↗ |
| 2022-07-05 | Giles Lisa M. | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 0.00 | — | 30,000 | — | ↗ |
| 2022-05-31 | TRUEX PAUL F | Director | M-Exempt | A | Common Shares | 8,016 | 1.12 | 9.0K | 8,016 | — | ↗ |
| 2022-03-21 | Oliveto Joseph | Officer | A-Award | A | Employee Stock Option Grant (right to buy) | 500,000 | 0.00 | — | 500,000 | — | ↗ |
| 2022-03-21 | Muller Lorenz | Officer | A-Award | A | Employee Stock Option Grant (right to buy) | 160,000 | 0.00 | — | 160,000 | — | ↗ |
| 2022-03-21 | Hasija Amit | Officer | A-Award | A | Employee Stock Option Grant (right to buy) | 175,000 | 0.00 | — | 175,000 | — | ↗ |
| 2022-02-15 | Bharucha David | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-14 | Wills Robert James | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 5.54 | 166.2K | 30,000 | — | ↗ |
| 2021-06-14 | TRUEX PAUL F | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 5.54 | 166.2K | 30,000 | — | ↗ |
| 2021-06-14 | TOMSICEK MICHAEL JOHN | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 5.54 | 166.2K | 30,000 | — | ↗ |
| 2021-06-14 | Pasternak Richard C | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 5.54 | 166.2K | 30,000 | — | ↗ |
| 2021-06-14 | Liebert Debra K. | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 5.54 | 166.2K | 30,000 | — | ↗ |
| 2021-06-14 | Giles Lisa M. | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 5.54 | 166.2K | 30,000 | — | ↗ |
| 2021-05-21 | RTW INVESTMENTS, LP | Director | P-Purchase | A | Pre-Funded Warrant | 910,746 | 0.01 | 9.1K | 8,518,257 | — | ↗ |
| 2021-03-24 | Plat Francis | Officer | A-Award | A | Employee Stock Option (right to buy) | 130,000 | 6.26 | 813.8K | 130,000 | — | ↗ |
| 2021-03-24 | Oliveto Joseph | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 670,000 | 6.26 | 4.19M | 670,000 | — | ↗ |
| 2021-03-24 | Muller Lorenz | Officer | A-Award | A | Employee Stock Option (right to buy) | 200,000 | 6.26 | 1.25M | 200,000 | — | ↗ |
| 2021-03-24 | Hasija Amit | Officer | A-Award | A | Employee Stock Option (right to buy) | 240,000 | 6.26 | 1.50M | 240,000 | — | ↗ |
| 2020-10-27 | RTW INVESTMENTS, LP | 10% Owner | P-Purchase | A | Pre-Funded Warrant | 952,380 | 0.01 | 9.5K | 7,607,511 | — | ↗ |
| 2020-10-01 | Wills Robert James | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-10-01 | Giles Lisa M. | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 7.10 | 213.0K | 30,000 | — | ↗ |
| 2020-08-26 | Muller Lorenz | Officer | M-Exempt | A | Common Stock | 5,700 | 1.54 | 8.8K | 108,386 | — | ↗ |
| 2020-07-29 | FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | 10% Owner | S-Sale | D | Common shares | 500,000 | 8.32 | 4.16M | 2,254,920 | — | ↗ |
| 2020-07-28 | FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | 10% Owner | S-Sale | D | Common shares | 19,863 | 8.10 | 160.9K | 2,754,920 | — | ↗ |
| 2020-07-22 | RTW INVESTMENTS, LP | 10% Owner | P-Purchase | A | Pre-Funded Warrant | 6,655,131 | 0.01 | 66.6K | 6,655,131 | — | ↗ |
| 2020-06-05 | TRUEX PAUL F | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 3.74 | 56.1K | 15,000 | — | ↗ |
| 2020-06-05 | TOMSICEK MICHAEL JOHN | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 3.74 | 56.1K | 15,000 | — | ↗ |
| 2020-06-05 | Plat Francis | Officer | A-Award | A | Employee Stock Option (right to buy) | 35,000 | 3.74 | 130.9K | 35,000 | — | ↗ |
| 2020-06-05 | Pasternak Richard C | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 3.74 | 56.1K | 15,000 | — | ↗ |
| 2020-06-05 | Oliveto Joseph | Officer | A-Award | A | Employee Stock Option (right to buy) | 150,000 | 3.74 | 561.0K | 150,000 | — | ↗ |
| 2020-06-05 | Muller Lorenz | Officer | A-Award | A | Employee Stock Option (right to buy) | 35,000 | 3.74 | 130.9K | 35,000 | — | ↗ |
| 2020-06-05 | Liebert Debra K. | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 3.74 | 56.1K | 15,000 | — | ↗ |
| 2020-06-05 | Hasija Amit | Officer | A-Award | A | Employee Stock Option (right to buy) | 115,000 | 3.74 | 430.1K | 115,000 | — | ↗ |
| 2020-06-05 | Edick Paul R | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 3.74 | 56.1K | 15,000 | — | ↗ |
| 2020-04-03 | Muller Lorenz | Officer | M-Exempt | A | Common Shares | 18,043 | 1.54 | 27.8K | 102,686 | — | ↗ |
| 2020-03-19 | RTW INVESTMENTS, LP | 10% Owner | P-Purchase | A | Common Shares | 5,870 | 10.87 | 63.8K | 4,315,102 | — | ↗ |
| 2020-03-18 | RTW INVESTMENTS, LP | 10% Owner | P-Purchase | A | Common Shares | 2,705 | 10.36 | 28.0K | 4,309,232 | — | ↗ |
| 2020-03-02 | RTW INVESTMENTS, LP | 10% Owner | P-Purchase | A | Common Shares | 78,263 | 18.95 | 1.48M | 4,306,527 | — | ↗ |
| 2020-01-23 | Plat Francis | Officer | A-Award | A | Employee Stock Option (right to buy) | 84,000 | 21.48 | 1.80M | 84,000 | — | ↗ |
| 2020-01-23 | Oliveto Joseph | Officer | A-Award | A | Employee Stock Option (right to buy) | 200,000 | 21.48 | 4.30M | 200,000 | — | ↗ |
| 2020-01-23 | Muller Lorenz | Officer | A-Award | A | Employee Stock Option (right to buy) | 60,000 | 21.48 | 1.29M | 60,000 | — | ↗ |
| 2020-01-23 | Hasija Amit | Officer | A-Award | A | Employee Stock Option (right to buy) | 82,000 | 21.48 | 1.76M | 82,000 | — | ↗ |
| 2020-01-13 | RTW INVESTMENTS, LP | 10% Owner | P-Purchase | A | Common Shares | 270,000 | 16.25 | 4.39M | 4,228,264 | — | ↗ |
| 2019-12-31 | RTW INVESTMENTS, LP | Director | P-Purchase | A | Common Shares | 21,438 | 15.50 | 332.3K | 3,958,264 | — | ↗ |
| 2019-12-30 | RTW INVESTMENTS, LP | 10% Owner | P-Purchase | A | Common Shares | 1,333 | 15.48 | 20.6K | 3,936,826 | — | ↗ |
| 2019-12-21 | Oliveto Joseph | Officer | M-Exempt | D | Employee Stock Option (right to buy) | 7,400 | 1.54 | 11.4K | 113,856 | — | ↗ |
| 2019-11-25 | Novo Holdings A/S | 10% Owner | S-Sale | D | COMMON SHARES | 240,000 | 16.00 | 3.84M | 2,434,470 | — | ↗ |
| 2019-11-20 | RTW INVESTMENTS, LP | 10% Owner | P-Purchase | A | Common Shares | 400,000 | 16.00 | 6.40M | 3,935,493 | — | ↗ |
| 2019-11-12 | TRUEX PAUL F | Director | A-Award | A | Stock Option (right to buy) | 4,000 | 17.78 | 71.1K | 4,000 | — | ↗ |
| 2019-11-12 | Pasternak Richard C | Director | A-Award | A | Stock Option (right to buy) | 19,000 | 17.78 | 337.8K | 19,000 | — | ↗ |
| 2019-11-12 | Liebert Debra K. | Director | A-Award | A | Stock Option (right to buy) | 19,000 | 17.78 | 337.8K | 19,000 | — | ↗ |
| 2019-11-11 | Pasternak Richard C | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-10-15 | RTW INVESTMENTS, LP | 10% Owner | P-Purchase | A | Common Shares | 1,100 | 18.00 | 19.8K | 3,535,493 | — | ↗ |
| 2019-10-11 | RTW INVESTMENTS, LP | 10% Owner | P-Purchase | A | Common Shares | 4,208 | 17.30 | 72.8K | 3,534,393 | — | ↗ |
| 2019-10-10 | RTW INVESTMENTS, LP | 10% Owner | P-Purchase | A | Common Shares | 179 | 16.00 | 2.9K | 3,530,185 | — | ↗ |
| 2019-10-03 | RTW INVESTMENTS, LP | 10% Owner | P-Purchase | A | Common Shares | 1,908 | 18.31 | 34.9K | 3,530,006 | — | ↗ |
| 2019-10-01 | RTW INVESTMENTS, LP | 10% Owner | P-Purchase | A | Common Shares | 6,242 | 17.63 | 110.0K | 3,528,098 | — | ↗ |
| 2019-10-01 | Muller Lorenz | Officer | M-Exempt | D | Employee Stock Option (right to buy) | 2,500 | 1.54 | 3.9K | 87,982 | — | ↗ |
| 2019-09-09 | Maness Timothy | Officer | A-Award | A | Employee Stock Option (right to buy) | 20,000 | 22.45 | 449.0K | 20,000 | — | ↗ |
| 2019-09-09 | Hasija Amit | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-05-13 | Novo Holdings A/S | 10% Owner | M-Exempt | A | COMMON SHARES | 964,089 | 0.00 | — | 2,341,137 | — | ↗ |
| 2019-05-13 | FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | 10% Owner | C-Conversion | D | Series C Preferred | 437,203 | 0.00 | — | 0 | — | ↗ |
| 2019-05-13 | Douville Philippe | Officer | C-Conversion | A | Common Shares | 4,124 | 0.00 | — | 43,392 | — | ↗ |
| 2019-05-09 | RTW INVESTMENTS, LP | 10% Owner | C-Conversion | A | Common Shares | 203,942 | 0.00 | — | 2,855,189 | — | ↗ |
| 2019-05-08 | TRUEX PAUL F | Director | — | D | Stock Option (right to buy) | 25,529 | 1.54 | 39.3K | 0 | — | ↗ |
| 2019-05-08 | TOMSICEK MICHAEL JOHN | Director | — | D | Stock Option (right to buy) | 27,447 | 9.42 | 258.6K | 0 | — | ↗ |
| 2019-05-08 | RTW INVESTMENTS, LP | 10% Owner | — | I | Class D-1 Preferred | 2,651,247 | 0.00 | — | 0 | — | ↗ |
| 2019-05-08 | Plat Francis | Officer | — | D | Employee Stock Option (right to buy) | 37,598 | 2.66 | 100.0K | 0 | — | ↗ |
| 2019-05-08 | Oliveto Joseph | Director / Officer | — | D | Employee Stock Option (right to buy) | 263,192 | 2.66 | 700.1K | 0 | — | ↗ |
| 2019-05-08 | Novo Holdings A/S | 10% Owner | — | D | CLASS D PREFERRED SHARES | 964,089 | 0.00 | — | 0 | — | ↗ |
| 2019-05-08 | Muller Lorenz | Officer | — | D | Common Shares | 0 | 0.00 | — | 49,615 | — | ↗ |
| 2019-05-08 | Maness Timothy | Officer | — | D | Employee Stock Option (right to buy) | 18,799 | 2.66 | 50.0K | 0 | — | ↗ |
| 2019-05-08 | Liebert Debra K. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-05-08 | Kumar Nilesh | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-05-08 | FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | 10% Owner | — | D | Common Shares | 0 | 0.00 | — | 30,567 | — | ↗ |
| 2019-05-08 | Edick Paul R | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-05-08 | Douville Philippe | Officer | — | D | Common Shares | 0 | 0.00 | — | 39,268 | — | ↗ |
| 2019-05-08 | Boorsma Marco | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-05-08 | BDC CAPITAL INC. | 10% Owner | — | I | Preferred Shares | 1,094,004 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-18.9K
Shares Outstanding
85.89M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Joseph Oliveto Chief Executive Officer & President | 649.6K | — | 538.1K | 651.5K | 250.1K | 31.6K | 2.12M | 56.09% | ↗ |
| 2 | 2025 | David Bharucha Chief Medical Officer | 504.2K | — | 162.4K | 197.6K | 141.2K | 19.1K | 1.02M | 35.14% | ↗ |
| 3 | 2025 | Amit Hasija Chief Financial Officer and Executive Vice President of Corporate Development | 472.8K | — | 162.4K | 197.6K | 132.4K | 26.7K | 991.9K | 36.30% | ↗ |
| 4 | 2024 | Joseph Oliveto Chief Executive Officer | 601.5K | — | — | — | 225.6K | 55.2K | 882.3K | 0.00% | ↗ |
| 5 | 2024 | Joseph Oliveto Chief Executive Officer & President | 601.5K | — | — | — | 225.6K | 27.2K | 854.3K | 0.00% | ↗ |
| 6 | 2024 | David Bharucha Chief Medical Officer | 458.4K | — | — | — | 137.5K | 12.4K | 608.2K | 0.00% | ↗ |
| 7 | 2024 | Amit Hasija Chief Financial Officer and Executive Vice President of Corporate Development | 437.8K | — | — | — | 114.9K | 20.3K | 573.4K | 0.00% | ↗ |
| 8 | 2023 | Joseph Oliveto Chief Executive Officer | 601.5K | — | — | 1.03M | 292.0K | 56.0K | 1.98M | 52.00% | ↗ |
| 9 | 2023 | David Bharucha Chief Medical Officer | 458.4K | — | — | 528.6K | 190.5K | 42.6K | 1.22M | 43.33% | ↗ |
| 10 | 2023 | Amit Hasija Chief Financial Officer and Executive Vice President of Corporate Development | 437.8K | — | — | 371.4K | 148.8K | 48.4K | 1.01M | 36.91% | ↗ |
| 11 | 2022 | Joseph Oliveto Chief Executive Officer | 584.0K | — | — | 2.06M | 266.3K | 55.5K | 2.97M | 69.46% | ↗ |
| 12 | 2022 | David Bharucha Chief Medical Officer | 391.1K | — | — | 1.61M | — | 18.4K | 2.02M | 79.72% | ↗ |
| 13 | 2022 | Amit Hasija Chief Financial Officer and Executive Vice President of Corporate Development | 425.0K | — | — | 721.4K | 135.5K | 42.6K | 1.32M | 54.46% | ↗ |
| 14 | 2021 | Joseph Oliveto Chief Executive Officer | 509.2K | — | — | 3.19M | 336.9K | 66.7K | 4.10M | 77.74% | ↗ |
| 15 | 2021 | Amit Hasija Chief Financial Officer and Executive Vice President of Corporate Development | 378.7K | — | — | 1.14M | 184.0K | 43.1K | 1.75M | 65.32% | ↗ |
| 16 | 2021 | Francis Plat Chief Science Officer | 404.9K | — | — | 618.5K | 165.1K | 16.1K | 1.20M | 51.34% | ↗ |
| 17 | 2020 | Joseph Oliveto Chief Executive Officer | 469.8K | — | — | 3.44M | 165.0K | 11.6K | 4.09M | 84.19% | ↗ |
| 18 | 2020 | Amit Hasija Chief Financial Officer and Executive Vice President of Corporate Development | 353.3K | — | — | 1.55M | 84.0K | 4.9K | 1.99M | 77.81% | ↗ |
| 19 | 2020 | Francis Plat Chief Medical Officer | 378.1K | — | — | 1.37M | 59.9K | — | 1.81M | 75.80% | ↗ |
| 20 | 2020 | Francis Plat Chief Science Officer | 378.1K | — | — | 1.37M | 59.9K | — | 1.81M | 75.80% | ↗ |
| 21 | 2019 | Amit Hasija Chief Financial Officer and Executive Vice President of Corporate Development | 121.3K | — | — | 2.30M | 45.5K | — | 2.46M | 93.23% | ↗ |
| 22 | 2019 | Timothy Maness Former Chief Accounting Officer | 292.9K | — | — | 818.6K | — | — | 1.11M | 73.65% | ↗ |
| 23 | 2019 | Joseph Oliveto Chief Executive Officer | 458.5K | — | — | — | 325.0K | 1.5K | 785.0K | 0.00% | ↗ |
| 24 | 2019 | Francis Plat Chief Medical Officer | 380.7K | — | — | — | 198.4K | — | 579.1K | 0.00% | ↗ |
| 25 | 2018 | Joseph Oliveto Chief Executive Officer | 360.0K | — | — | 866.7K | 190.0K | 20.2K | 1.44M | 60.32% | ↗ |
| 26 | 2018 | Francis Plat Chief Medical Officer | 330.0K | — | — | 223.6K | 83.0K | — | 636.6K | 35.13% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Joseph G. Oliveto | Chief Executive Officer, President & Director | 931.4K | male |
| David Bharucha FACC | Chief Medical Officer | 664.4K | — |
| Amit Hasija | Chief Financial Officer & Executive Vice President of Corporate Development | 631.9K | male |
| Lorenz Muller | Chief Commercial Officer | 397.5K | male |
| Jeff Moore | Vice President of Sales | — | male |
| Jeff Nelson | Chief Operating Officer | — | male |
| Philip T. Sager FACC FAHA FHRS | Chief Medical Advisor & Member of the Scientific Advisory Board | — | — |
| Philippe Douville | Founder, Strategic Advisor & Member of Scientific Advisory Board | — | — |
| Roshan Girglani | Vice President of Marketing | — | male |
| Anita Holz | Vice President & Head of Medical Affairs | — | female |
| David Sandoval | General Counsel & Chief Compliance Officer | — | male |
| Guy Rousseau | SVP of Regulatory Affairs and Quality Management | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MIST
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
